Ibrutinib treatment ameliorates murine chronic graft-versus-host disease
Author(s) -
Jason A. Dubovsky,
Ryan T. Flynn,
Jing Du,
Bonnie K. Harrington,
Yiming Zhong,
Benjamin H. Kaffenberger,
Carrie Yang,
William H. Towns,
Amy Lehman,
Amy J. Johnson,
Natarajan Muthusamy,
Steven M. Devine,
Samantha Jaglowski,
Jonathan S. Serody,
William J. Murphy,
David H. Munn,
Leo Luznik,
Geoffrey R. Hill,
Henry K. Wong,
Kelli P. A. MacDonald,
Ivan Maillard,
John Koreth,
Laurence Elias,
Corey Cutler,
Robert J. Soiffer,
Joseph H. Antin,
Jerome Ritz,
Angela PanoskaltsisMortari,
John C. Byrd,
Bruce R. Blazar
Publication year - 2014
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - Uncategorized
DOI - 10.17615/vfd1-7m89
Subject(s) - ibrutinib , graft versus host disease , medicine , host (biology) , disease , oncology , biology , leukemia , chronic lymphocytic leukemia , ecology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom